Cognition Therapeutics, Inc. (CGTX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -5.54M | -3.44M | -5.65M | -5.62M | -9.88M | -8.38M | -6.85M | -6M | -7.24M | -5.46M | -4.16M | -3.7M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 43.89% | 59% | 17.52% | 6.24% | -36.35% | -53.63% | -64.65% | -62.26% | -167.8% | 46.43% | -103925% | 31.01% |
| Net Income | -4.57M | -3.34M | -4.93M | -6.73M | -8.48M | -7.84M | -9.94M | -7.04M | -9.15M | -8.14M | -6.75M | -4.73M |
| Depreciation & Amortization | 68K | 61K | 61K | 61K | 45K | 71K | 70K | 67K | 58K | 66K | 65K | 61K |
| Stock-Based Compensation | 330K | 0 | 522K | 621K | 586K | 534K | 896K | 1.15M | 1.17M | 1.07M | 1.07M | 1.02M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -846K | 0 | -691K |
| Other Non-Cash Items | -1.37M | 399K | 0 | 0 | 0 | 0 | 0 | 0 | 195K | 841K | 5K | 691K |
| Working Capital Changes | 0 | -554K | -1.3M | 429K | -2.03M | -1.15M | 2.12M | -170K | 483K | 1.55M | 1.45M | -56K |
| Change in Receivables | 0 | -8.02M | 4.38M | -1.51M | -2.09M | 683K | -270K | -2.24M | 420K | 357K | 755K | -784K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.43M | -456K |
| Change in Payables | -7.57M | 8.41M | -5.44M | 614K | -75K | 0 | 0 | 1.73M | -377K | 0 | 672K | 1.24M |
| Cash from Investing | 0 | 9K | 0 | 0 | 0 | -1K | 0 | -3K | 0 | -30K | -58K | -18K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | -1K | 0 | -3K | 0 | -30K | -58K | -18K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 9K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -233K | 605K | 33.92M | 752K | 1.3M | 11.38M | 329K | -138K | 11.99M | 2.44M | -3K | 2.1M |
| Debt Issued (Net) | 0 | -74K | -41K | -120K | -118K | -195K | -185K | -181K | -178K | -179K | -215K | -210K |
| Equity Issued (Net) | 0 | 756K | 33.99M | 877K | 1.46M | 11.58M | 497K | 65K | 12.28M | 2.62M | 212K | 2.31M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -233K | -77K | -36K | -5K | -46K | 0 | 17K | -22K | -106K | 0 | 0 | 0 |
| Net Change in Cash | -5.78M | -2.82M | 28.27M | -4.87M | -8.58M | 3M | -6.52M | -6.14M | 4.75M | -3.05M | -4.22M | -1.62M |
| Free Cash Flow | -5.54M | -3.44M | -5.65M | -5.62M | -9.88M | -8.38M | -6.85M | -6M | -7.24M | -5.49M | -4.22M | -3.71M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 43.89% | 59% | 17.52% | 6.28% | -36.35% | -52.81% | -62.38% | -61.55% | -163.8% | 46.18% | -15525.93% | 30.72% |
| FCF per Share | -0.06 | -0.04 | -0.07 | -0.09 | -0.16 | -0.18 | -0.17 | -0.15 | -0.21 | -0.18 | -0.14 | -0.13 |
| FCF Conversion (FCF/Net Income) | - | 1.03x | 1.15x | 0.84x | 1.16x | 1.07x | 0.69x | 0.85x | 0.79x | 0.67x | 0.62x | 0.78x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |